These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 21268797

  • 1. What to make of the new warning on bisphosphonates. Officials acknowledge a connection between the most popular bone drugs and rare thigh fractures.
    Harv Womens Health Watch; 2010 Dec; 18(4):6-7. PubMed ID: 21268797
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Study finds no link between bone drugs and unusual thigh fractures.
    Harv Womens Health Watch; 2010 Jul; 17(11):6. PubMed ID: 20684079
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. News on bisphosphonates: but will patterns of use change?
    Garg A.
    Dent Implantol Update; 2010 Sep; 21(9):71-2. PubMed ID: 20863016
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonates and atypical femoral fractures.
    Hofbauer LC, Jakob F, Felsenberg D.
    N Engl J Med; 2010 Sep 09; 363(11):1084; author reply 1084-5. PubMed ID: 20848679
    [No Abstract] [Full Text] [Related]

  • 9. Warning: bisphosphonates and osteochemonecrosis of the jaws.
    Flint SR, Sharkey S, Galvin S.
    J Ir Dent Assoc; 2006 Sep 09; 52(2):79-83. PubMed ID: 16989369
    [Abstract] [Full Text] [Related]

  • 10. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T.
    Clin Calcium; 2010 Nov 09; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract] [Full Text] [Related]

  • 11. New annual osteoporosis drug reduces risk of death, future fractures. Infused dose is more convenient for patients, enhances overall quality of life.
    Duke Med Health News; 2007 Dec 09; 13(12):8. PubMed ID: 18286732
    [No Abstract] [Full Text] [Related]

  • 12. In brief: duration of use of bisphosphonates.
    Med Lett Drugs Ther; 2011 Oct 03; 53(1374):77. PubMed ID: 21959355
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL.
    Gen Dent; 2007 Oct 03; 55(1):8-10. PubMed ID: 17333956
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. More on atypical fractures of the femoral diaphysis.
    Lee P, Seibel MJ.
    N Engl J Med; 2008 Jul 17; 359(3):317; author reply 317-8. PubMed ID: 18642421
    [No Abstract] [Full Text] [Related]

  • 18. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
    Horning JA, Czajka J, Uhl RL.
    Orthopedics; 2010 Dec 17; 33(12):902. PubMed ID: 21117565
    [No Abstract] [Full Text] [Related]

  • 19. Bisphosphonates in the treatment of osteoporosis.
    Diab DL, Watts NB.
    Endocrinol Metab Clin North Am; 2012 Sep 17; 41(3):487-506. PubMed ID: 22877426
    [Abstract] [Full Text] [Related]

  • 20. Evolving data about subtrochanteric fractures and bisphosphonates.
    Shane E.
    N Engl J Med; 2010 May 13; 362(19):1825-7. PubMed ID: 20335574
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.